
NOVOGENE CO., LTD. — Investor Relations & Filings
Novogene Co., Ltd. is a global provider of genomic services and solutions, specializing in next-generation sequencing (NGS) and bioinformatics analysis. The company offers a comprehensive suite of services, including whole genome sequencing, transcriptomics, epigenomics, and metagenomics, alongside specialized solutions for single-cell analysis and clinical diagnostics. Utilizing advanced high-throughput sequencing platforms and proprietary bioinformatics pipelines, Novogene supports research across diverse fields such as human health, agriculture, and environmental science. The organization serves a broad client base encompassing academic institutions, pharmaceutical companies, and biotechnology firms. With a focus on data quality and technical expertise, Novogene facilitates large-scale genomic studies and precision medicine initiatives through its network of high-capacity laboratories and integrated data management systems.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 北京诺禾致源科技股份有限公司非经常性损益及净资产收益率和每股收益的专项审核报告 | 2022-03-23 | Chinese | |
| 北京诺禾致源科技股份有限公司内部控制鉴证报告 | 2022-03-23 | Chinese | |
| 北京诺禾致源科技股份有限公司关于最近五年不存在被证券监管部门和交易所采取监管措施或处罚情况的公告 | 2022-03-23 | Chinese | |
| 北京诺禾致源科技股份有限公司第二届董事会第二十四次会议决议公告 | 2022-03-23 | Chinese | |
| 北京诺禾致源科技股份有限公司募集资金年度存放与使用情况鉴证报告 | 2022-03-23 | Chinese | |
| 北京诺禾致源科技股份有限公司2022年度向特定对象发行A股股票发行方案论证分析报告 | 2022-03-23 | Chinese |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2022
15 filings
| |||||
| 38992513 | 北京诺禾致源科技股份有限公司非经常性损益及净资产收益率和每股收益的专项审核报告 | 2022-03-23 | Chinese | ||
| 38992468 | 北京诺禾致源科技股份有限公司内部控制鉴证报告 | 2022-03-23 | Chinese | ||
| 38992316 | 北京诺禾致源科技股份有限公司关于最近五年不存在被证券监管部门和交易所采取监管措施或处罚情况的公告 | 2022-03-23 | Chinese | ||
| 38992310 | 北京诺禾致源科技股份有限公司第二届董事会第二十四次会议决议公告 | 2022-03-23 | Chinese | ||
| 38992300 | 北京诺禾致源科技股份有限公司募集资金年度存放与使用情况鉴证报告 | 2022-03-23 | Chinese | ||
| 38992219 | 北京诺禾致源科技股份有限公司2022年度向特定对象发行A股股票发行方案论证分析报告 | 2022-03-23 | Chinese | ||
| 38992177 | 北京诺禾致源科技股份有限公司2022年向特定对象发行A股股票募集资金使用的可行性分析报告 | 2022-03-23 | Chinese | ||
| 38992156 | 北京诺禾致源科技股份有限公司2022年第二次临时股东大会通知 | 2022-03-23 | Chinese | ||
| 38992127 | 北京诺禾致源科技股份有限公司第二届监事会第十五次会议决议公告 | 2022-03-23 | Chinese | ||
| 38992103 | 未来三年股东分红回报规划 | 2022-03-23 | Chinese | ||
| 38992076 | 北京诺禾致源科技股份有限公司前次募集资金使用情况的专项报告 | 2022-03-23 | Chinese | ||
| 38992058 | 北京诺禾致源科技股份有限公司关于向特定对象发行A股股票摊薄即期回报与填补措施及相关主体承诺的公告 | 2022-03-23 | Chinese | ||
| 38992034 | 北京诺禾致源科技股份有限公司2022年向特定对象发行A股股票预案 | 2022-03-23 | Chinese | ||
| 38992012 | 北京中伦律师事务所关于北京诺禾致源科技股份有限公司2022年第一次临时股东大会的法律意见书 | 2022-03-08 | Chinese | ||
| 38991996 | 北京诺禾致源科技股份有限公司2022年第一次临时股东大会决议公告 | 2022-03-08 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
NOVOGENE CO., LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/58330/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=58330 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=58330 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=58330 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 58330}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for NOVOGENE CO., LTD. (id: 58330)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.